Horiko Capital Management LLC Organon & Co. Transaction History

Horiko Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $423,142 - $619,342	-18,083 Reduced 10.56%	153,088 $3.58 Million
Q2 2022 Aug 15, 2022	BUY	$31.66 - $38.9 $859,379 - $1.06 Million	27,144 Added 18.85%	171,171 $5.78 Million
Q1 2022 May 16, 2022	BUY	$30.45 - $39.36 $943,280 - $1.22 Million	30,978 Added 27.4%	144,027 $5.03 Million
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $3.24 Million - $4.2 Million	113,049 New	113,049 $3.44 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Horiko Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Horiko Capital Management LLC with notifications on news.